DEXAMPEX Drug Patent Profile
✉ Email this page to a colleague
When do Dexampex patents expire, and what generic alternatives are available?
Dexampex is a drug marketed by Teva and is included in two NDAs.
The generic ingredient in DEXAMPEX is dextroamphetamine sulfate. There are eighteen drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the dextroamphetamine sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Dexampex
A generic version of DEXAMPEX was approved as dextroamphetamine sulfate by BARR on January 31st, 2001.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DEXAMPEX?
- What are the global sales for DEXAMPEX?
- What is Average Wholesale Price for DEXAMPEX?
Summary for DEXAMPEX
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 22 |
Patent Applications: | 5,145 |
Formulation / Manufacturing: | see details |
DailyMed Link: | DEXAMPEX at DailyMed |
![DEXAMPEX drug patent expirations Drug patent expirations by year for DEXAMPEX](/p/graph/s/t/DEXAMPEX-patent-expirations.png)
US Patents and Regulatory Information for DEXAMPEX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Teva | DEXAMPEX | dextroamphetamine sulfate | CAPSULE;ORAL | 085355-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Teva | DEXAMPEX | dextroamphetamine sulfate | TABLET;ORAL | 083735-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Teva | DEXAMPEX | dextroamphetamine sulfate | TABLET;ORAL | 083735-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |